These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2170534)

  • 1. Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.
    Polonelli L; Fanti F; Conti S; Campani L; Gerloni M; Castagnola M; Morace G; Chezzi C
    J Immunol Methods; 1990 Sep; 132(2):205-9. PubMed ID: 2170534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yeast killer toxin-like anti-idiotypic antibodies.
    Polonelli L; Morace G
    J Clin Microbiol; 1988 Mar; 26(3):602-4. PubMed ID: 2451680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Antibiobodies': antibiotic-like anti-idiotypic antibodies.
    Polonelli L; Conti S; Gerloni M; Magliani W; Castagnola M; Morace G; Chezzi C
    J Med Vet Mycol; 1991; 29(4):235-42. PubMed ID: 1941431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.
    Polonelli L; Beninati C; Teti G; Felici F; Ciociola T; Giovati L; Sperindè M; Lo Passo C; Pernice I; Domina M; Arigò M; Papasergi S; Mancuso G; Conti S; Magliani W
    PLoS One; 2014; 9(8):e105727. PubMed ID: 25162681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
    Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
    J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
    Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
    Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
    FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential toxinogenesis in the genus Pichia detected by an anti-yeast killer toxin monoclonal antibody.
    Polonelli L; Conti S; Campani L; Gerloni M; Morace G; Chezzi C
    Antonie Van Leeuwenhoek; 1991 Apr; 59(3):139-45. PubMed ID: 1907819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological study of yeast killer toxins by monoclonal antibodies.
    Polonelli L; Manzara S; Conti S; Dettori G; Morace G; Chezzi C
    Mycopathologia; 1989 Dec; 108(3):211-5. PubMed ID: 2515441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity.
    Polonelli L; Lorenzini R; De Bernardis F; Gerloni M; Conti S; Morace G; Magliani W; Chezzi C
    Scand J Immunol; 1993 Jan; 37(1):105-10. PubMed ID: 8418467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfaces of the yeast killer phenomenon.
    Polonelli L; Conti S; Gerloni M; Magliani W; Chezzi C; Morace G
    Crit Rev Microbiol; 1991; 18(1):47-87. PubMed ID: 1854433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.
    Conti S; Fanti F; Magliani W; Gerloni M; Bertolotti D; Salati A; Cassone A; Polonelli L
    J Infect Dis; 1998 Mar; 177(3):807-11. PubMed ID: 9498471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
    Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer anti-idiotypes in the control of fungal infections.
    Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
    Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical importance of yeast killer toxin].
    Cerikcioğlu N
    Mikrobiyol Bul; 2003; 37(2-3):215-21. PubMed ID: 14593905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro leishmanicidal activity of a monoclonal antibody mimicking a yeast killer toxin.
    Savoia D; Avanzini C; Conti S; Magliani V; Frazzi R; Polonelli L
    J Eukaryot Microbiol; 2002; 49(4):319-23. PubMed ID: 12188222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of anti-toxin antibodies by immunization with Pichia killer toxin-like antiidiotypic monoclonal antibodies.
    Snyder C; Seguy N; Lafitte S; Guyard C; Polonelli L; Cailliez JC; Grzych JM
    J Eukaryot Microbiol; 1999; 46(5):138S. PubMed ID: 10519290
    [No Abstract]   [Full Text] [Related]  

  • 20. Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies.
    Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
    J Biochem; 2010 May; 147(5):723-33. PubMed ID: 20097900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.